Schneyer Mark C.

Schneyer Mark C. is listed in filings as EVP at ACADIA Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through May 5, 2026, including sale activity. Recent filings connect the profile to ACADIA Pharmaceuticals Inc. (ACAD). The current snapshot covers public activity from Jun 11, 2024 to May 5, 2026. Reported amounts are shown as $76.4K to $804. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.